Picture of Ose Immunotherapeutics SA logo

OSE — Ose Immunotherapeutics SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: OSE Immunotherapeutics Announces New Public Grant In Field Of RNA Therapeutics

Aug 1 (Reuters) - OSE Immunotherapeutics SA  OSE.PA :
    * ANNOUNCED THAT THE COMPANY HAS RECEIVED €200,000 GRANT
INNOVATION FUNDING FROM THE FRENCH GOVERNMENT AND REGION PAYS DE
LA LOIRE AS PART OF THE “FRANCE 2030 INVESTMENT PLAN” OPERATED
BY BPIFRANCE.

Source text for Eikon:  ID:nBwlvQPda 
Further company coverage:  OSE.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Ose Immunotherapeutics SA

See all news